Medical specialists from Israel tagged as investigators in clinical trials studying Neoplasm Metastasis
Total 27 results
-
Alexander Lossos, Dr.Seen in:
- Jerusalem, Hadassah Medical Organization
- Jerusalem, Reaserch Fund of the Hadassah Medical Organization
Trials:- NCT02831959 (Principal Investigator)
- NCT04250922 (Principal Investigator)
-
Amir SonnenblickSeen in:
- Tel Aviv, Tel Aviv Sourasky Medical Center
- Tell Abīb, Tel Aviv, Sourasky Medical Center
Trials:- NCT05169567 (Principal Investigator)
- NCT03053193 (Principal Investigator)
- NCT05514054 (Principal Investigator)
Conditions: -
Amit ItaySeen in:
- HaMerkaz, Ramat Gan, Sheba Medical Center
Trials:- NCT05169567 (Principal Investigator)
Conditions: -
Andrew Kanner, M.D.Seen in:
- Tel Aviv, Radiotherapy Department, TASMC
Trials:- NCT00781209 (Sub-Investigator)
Conditions: -
aronp@clalit.org.il aronp@clalit.org.il, Dr.Seen in:
- Petah Tikva, Rabin Medical Center
Trials:- NCT02831959 (Principal Investigator)
-
Avivit PeerSeen in:
- HaTsafon, Haifa, Rambam Health Care Campus
- Ḥeifā, Haifa, Oncology
- Ḥeifā, Haifa, Rambam Health Care Campus
Trials:- NCT05288166 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6
-
Daniel Keizman, MDSeen in:
- Kfar-Saba, Institute of Oncology, Meir Medical Center
Trials:- NCT01814150 (Principal Investigator)
-
David SaridSeen in:
- Other, Tel Aviv, Tel Aviv Sourasky Medical Center
- Tel Aviv, Tel-Aviv Sourasky Medical Centre
- Tell Abīb, Tel Aviv, Oncology
- Tell Abīb, Tel Aviv, Sourasky Medical Center
Trials:- NCT05288166 (Principal Investigator)
- NCT04879329 (Principal Investigator)
- NCT03127631 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6;
- Urothelial Carcinoma;
- Cardiovascular Disease;
- Prostate Cancer
-
Deborah Blumenthal, M.D.Seen in:
- Tel Aviv, Radiotherapy Department, TASMC
Trials:- NCT00781209 (Sub-Investigator)
Conditions: -
Deborah Deborah, Prof. Dr.Seen in:
- Tel Aviv, Sourasky Medical Center
Trials:- NCT02831959 (Principal Investigator)
-
Eli RosenbaumSeen in:
- HaMerkaz, Petah Tikva, Oncology
- HaMerkaz, Petah Tikva, Rabin Medical Center
Trials:- NCT05288166 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6
-
Felix Bokstein, M.D.Seen in:
- Tel Aviv, Radiotherapy Department, TASMC
Trials:- NCT00781209 (Sub-Investigator)
Conditions: -
Igal KushnirSeen in:
- HaMerkaz, Kfar Saba, Meir Medical Center
Trials:- NCT05288166 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6
-
Iryna KuchukSeen in:
- HaMerkaz, Kfar Saba, Meir Medical Center
Trials:- NCT05169567 (Principal Investigator)
- NCT05514054 (Principal Investigator)
Conditions: -
Jonathan CohenSeen in:
- Jerusalem, Hadassah Medical Center
- Jerusalem, Hadassah Medical Center - PPDS_Investigational Site Number : 3760005
Trials:- NCT05584670 (Principal Investigator)
- NCT04777994 (Principal Investigator)
Conditions: -
Leor Zach, MDSeen in:
- Ramat Gan, Sheba Medical Center
Trials:- NCT02831959 (Principal Investigator)
-
Luna KadouriSeen in:
- Yerushalayim, Jerusalem, Hadassah Medical Center
Trials:- NCT05169567 (Principal Investigator)
Conditions: -
Margarita TokarSeen in:
- HaDarom, Be'er Sheva, Soroka Medical Center
Trials:- NCT05169567 (Principal Investigator)
- NCT05514054 (Principal Investigator)
Conditions: -
Michal SarfatySeen in:
- HaMerkaz, Ramat Gan, Oncology
- HaMerkaz, Ramat Gan, Sheba Medical Center
- Other, Ramat Gan, Sheba Medical Center
Trials:- NCT05288166 (Principal Investigator)
- NCT04879329 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6;
- Urothelial Carcinoma
-
Orit Kaidar-Person, Dr.Seen in:
- Haifa, Rambam Medical Center
Trials:- NCT02831959 (Principal Investigator)
-
Pinchas Klein, M.D.Seen in:
- Ramat Gan, Sheba Medical Center
Trials:- NCT05078853 (Sub-Investigator)
Conditions: -
Raya LeibowitzSeen in:
- HaMerkaz, Zerifin, Oncology
- HaMerkaz, Zerifin, Yitzhak Shamir Medical Center
Trials:- NCT05288166 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6
-
Raya Leibowitz-AmitSeen in:
- HaMerkaz, Zerifin, Yitzhak Shamir Medical Center
Trials:- NCT05288166 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6
-
Rinat YerushalmiSeen in:
- HaMerkaz, Petah Tikva, Rabin Medical Center
- HaMerkaz, Petah-Tikva, Rabin Medical Center
Trials:- NCT05169567 (Principal Investigator)
- NCT05514054 (Principal Investigator)
Conditions: -
Stephen Jay FrankSeen in:
- Yerushalayim, Jerusalem, Hadassah Medical Center
- Yerushalayim, Jerusalem, Oncology
Trials:- NCT05288166 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6
-
Talia GolanSeen in:
- HaMerkaz, Ramat Gan, Sheba Medical Center
- Ramat Gan, Sheba MC
- Ramat Gan, Sheba Medical Center
- Ramat Gan, Tel Hashomer, Sheba Medical Center
- Ramat Gan, The Chaim Sheba Medical Center
Trials:- NCT03906331 (Principal Investigator)
- NCT03157128 (Principal Investigator)
- NCT04777994 (Principal Investigator)
- NCT04431258 (Principal Investigator)
- NCT04970056 (Principal Investigator)
- NCT04417465 (Principal Investigator)
Conditions:- Breast Cancer;
- Pancreatic Cancer;
- Non Small Cell Lung Cancer;
- Colon Cancer;
- Medullary Thyroid Cancer;
- Papillary Thyroid Cancer;
- Other Solid Tumors With Evidence of Activating RET Alteration;
- Non-Small Cell Lung Cancer;
- Any Solid Tumor;
- Advanced Solid Tumor Cancer;
- Pancreatic Ductal Adenocarcinoma;
- Pancreas Cancer;
- Genetic Predisposition;
- Pancreas Cyst;
- Advanced Solid Tumors Cancer
-
Zvi Bernstein, MDSeen in:
- Haifa, Rambam Health Care Campus
Trials:- NCT00192777 (Sub-Investigator)
Conditions:
Clinical Trials on Neoplasm Metastasis
-
Betta Pharmaceuticals Co., Ltd.Recruiting
-
BayerCompleted
-
BayerCompletedNeoplasm Metastasis / Bone and BonesBelgium, Spain, Taiwan, United States, Japan, Russian Federation, Canada, Finland, Korea, Republic of, Singapore, Australia, Germany, Israel, United Kingdom, Italy, France, Poland, Brazil, Czechia, Norway, Sweden, Hong Kong
-
National Cancer Institute (NCI)TerminatedCancer | Neoplasm Metastasis | Metastasis | Neoplasm | Radiation OncologyUnited States
-
MedtronicNeuroCompletedMetastasis Spine | Metastasis to BoneUnited States, Luxembourg, Germany, France, Canada
-
Cho Ray HospitalUniversity of Medicine and Pharmacy at Ho Chi Minh CityRecruitingSynchronous Neoplasm | Liver Metastasis Colon CancerVietnam
-
Li MinRecruiting
-
Da FuGanzhou City People's HospitalRecruiting
-
University of Mississippi Medical CenterCompletedMetastasisUnited States
-
Assiut UniversityNot yet recruiting